TherapeuticsmdTXMD
13F holders, Q3 2024 (September 30)37holders −1
3new positions
5sold out
$1.66avg. 13F price*
At the end of Q3 2024, 37 institutions reported holding Therapeuticsmd Inc. (TXMD) in their 13F filings, down 1 from Q2 2024. 3 opened new positions and 5 sold out. The largest holders were Rubric Capital Management LP ($2.0M), Clearline Capital LP ($1.1M) and Tejara Capital Ltd ($666K).
- Company
- Therapeuticsmd Inc.
- CUSIP
- 88338N206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $1K |
| Exits | 5 | $45K |
All 13F filers, Q2 2024 → Q3 2024: 13,587 shares bought and 34,190 shares sold, net −20,603 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| Rubric Capital Management LP | 0.03% | No change | 1,192,191 | $2.0M |
| Clearline Capital LP | 0.09% | No change | 636,622 | $1.1M |
| Tejara Capital Ltd | 0.32% | Reduce -0.1% | 401,446 | $666K |
| Vanguard Group Inc. | 0.00% | No change | 387,582 | $643K |
| ADAR1 Capital Management, LLC | 0.08% | No change | 270,160 | $448K |
| Morgan Stanley | 0.00% | Add +0.1% | 131,719 | $219K |
| BlackRock, Inc. | 0.00% | — | 116,132 | $193K |
| Geode Capital Management, LLC | 0.00% | Add +13.5% | 108,333 | $180K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 34,000 | $56K |
| State Street Corp. | 0.00% | No change | 30,100 | $50K |
| Ameriprise Financial Inc. | 0.00% | No change | 22,470 | $37K |
| Northern Trust Corp. | 0.00% | No change | 16,457 | $27K |
| J. Goldman & Co LP | 0.00% | No change | 13,562 | $23K |
| FMR LLC | 0.00% | No change | 8,289 | $14K |
| UBS Group AG | 0.00% | Reduce -46.8% | 4,847 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -35.8% | 2,270 | $4K |
| National Bank of Canada | 0.00% | No change | 610 | $1K |
| Earned Wealth Advisors, LLC | 0.00% | New | 600 | $996 |
| Bank of America Corp. | 0.00% | Add +1.4% | 494 | $820 |
| JPMorgan Chase & Co. | 0.00% | No change | 293 | $486 |
| US Bancorp \de | 0.00% | No change | 246 | $408 |
| Wells Fargo & Company | 0.00% | Reduce -15.8% | 144 | $239 |
| Principal Securities, Inc. | 0.00% | No change | 126 | $209 |
| Huntington National Bank | 0.00% | No change | 120 | $199 |
| IFP Advisors, Inc | 0.00% | No change | 80 | $133 |
| Osaic Holdings, Inc. | 0.00% | No change | 56 | $92 |
| Activest Wealth Management | 0.00% | No change | 40 | $66 |
| Provenance Wealth Advisors, LLC | 0.00% | No change | 20 | $33 |
| Harbour Investments, Inc. | 0.00% | No change | 8 | $13 |
| Assetmark, Inc. | 0.00% | New | 4 | $7 |
| Guardian Wealth Management, Inc. | 0.00% | No change | 2 | $3 |
| Sterling Capital Management LLC | 0.00% | — | 1 | $2 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 1 | $2 |
| Aspire Private Capital, LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -34.2% | 154 | $0 |
| Simplex Trading, LLC | 0.00% | New | 2 | $0 |
| Tsfg, LLC | 0.00% | No change | 64 | $0 |
"% of holder's portfolio" is TXMD's weight in each manager's 13F, not the share of Therapeuticsmd Inc. the manager owns.